RPS15 mutations prevalent in aggressive chronic lymphocytic leukemiaMarch 16, 2016Leukemia, Myelodysplasia, Transplantation
Idelalisib use halted in six combo therapy trials, FDA announcesMarch 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Guidelines on asparaginase hypersensitivity and silent inactivation in ALLMarch 11, 2016Leukemia, Myelodysplasia, Transplantation
Children who have stem cell transplants need skin exams, sun protectionMarch 7, 2016MelanomaPediatricsLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Ibrutinib approved as first-line therapy for all CLL patientsMarch 7, 2016Leukemia, Myelodysplasia, Transplantation
Ponatinib effective in chronic phase CML regardless of baseline mutation statusFebruary 20, 2016Leukemia, Myelodysplasia, Transplantation
FDA gives breakthrough status to midostaurin for AMLFebruary 19, 2016Leukemia, Myelodysplasia, Transplantation
Resources limit availability of bone marrow transplantsFebruary 9, 2016Leukemia, Myelodysplasia, Transplantation
Survivors of childhood ALL show significant attention problemsFebruary 8, 2016Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Novel test detects low levels of residual CMLFebruary 6, 2016Leukemia, Myelodysplasia, Transplantation
Venetoclax shows promise for relapsed CLL, SLLFebruary 4, 2016Leukemia, Myelodysplasia, Transplantation
Acalabrutinib yields 95% overall response in relapsed CLLJanuary 27, 2016Leukemia, Myelodysplasia, Transplantation
Gemtuzumab ozogamicin boosts overall survival in older AML patientsJanuary 25, 2016Leukemia, Myelodysplasia, Transplantation
CAR T-cells induce remissions, avoid GVHD in relapsed B-cell malignanciesJanuary 25, 2016Leukemia, Myelodysplasia, Transplantation
CD30 identified as novel target in systemic mastocytosisJanuary 25, 2016Leukemia, Myelodysplasia, Transplantation
